SAGE

Sage Therapeutics, Inc.

Insider trading activity for Sage Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 40 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jul 31, 2025	Shiferman Gregory L.	See Remarks	DTOISS◆	28,000	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Shiferman Gregory L.	See Remarks	DTOISS◆	10,000	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Shiferman Gregory L.	See Remarks	DTOISS	23,735	—	—	-100.0%	Open the original filing on SEC.gov
Jul 31, 2025	Shiferman Gregory L.	See Remarks	UTENDR	7,215	—	—	-100.0%	Open the original filing on SEC.gov
Jul 31, 2025	Quirk Michael C.	See Remarks	DTOISS◆	4,000	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Quirk Michael C.	See Remarks	DTOISS◆	36,000	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Quirk Michael C.	See Remarks	DTOISS	7,962	—	—	-100.0%	Open the original filing on SEC.gov
Jul 31, 2025	Quirk Michael C.	See Remarks	DTOISS	24,999	—	—	-100.0%	Open the original filing on SEC.gov
Jul 31, 2025	Greene Barry E	President and CEO	DTOISS◆	174,000	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Greene Barry E	President and CEO	DTOISS	53,229	—	—	-100.0%	Open the original filing on SEC.gov
Jul 31, 2025	Greene Barry E	President and CEO	UTENDR	46,940	—	—	-100.0%	Open the original filing on SEC.gov
Jul 31, 2025	Golumbeski George	Director	DTOISS◆	21,500	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Golumbeski George	Director	DTOISS◆	13,593	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Golumbeski George	Director	UTENDR	8,000	—	—	-100.0%	Open the original filing on SEC.gov
Jul 31, 2025	Germano Geno J	Director	DTOISS◆	21,500	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Federer Jessica	Director	DTOISS◆	21,500	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Frates James M	Director	DTOISS◆	21,500	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Frates James M	Director	DTOISS◆	19,154	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Frates James M	Director	UTENDR	2,845	—	—	-100.0%	Open the original filing on SEC.gov
Jul 31, 2025	Cola Michael F	Director	DTOISS◆	21,500	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Benecchi Christopher	Chief Operating Officer	DTOISS◆	40,000	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Benecchi Christopher	Chief Operating Officer	DTOISS◆	12,500	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Benecchi Christopher	Chief Operating Officer	DTOISS	36,375	—	—	-100.0%	Open the original filing on SEC.gov
Jul 31, 2025	Benecchi Christopher	Chief Operating Officer	DTOISS	28,053	—	—	-100.0%	Open the original filing on SEC.gov
Jul 31, 2025	Barrett Elizabeth A.	Director	DTOISS◆	21,500	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Barrett Elizabeth A.	Director	UTENDR	3,000	—	—	-100.0%	Open the original filing on SEC.gov
Jun 24, 2025	Shiferman Gregory L.	See Remarks	FTAX	79	$9.22	$728	-0.3%	Open the original filing on SEC.gov
Jun 24, 2025	Quirk Michael C.	See Remarks	FTAX	113	$9.22	$1K	-0.4%	Open the original filing on SEC.gov
Jun 11, 2025	Golumbeski George	Director	AGRANT◆	21,500	—	—	—	Open the original filing on SEC.gov
Jun 11, 2025	Germano Geno J	Director	AGRANT◆	21,500	—	—	—	Open the original filing on SEC.gov
Jun 11, 2025	Federer Jessica	Director	AGRANT◆	21,500	—	—	—	Open the original filing on SEC.gov
Jun 11, 2025	Frates James M	Director	AGRANT◆	21,500	—	—	—	Open the original filing on SEC.gov
Jun 11, 2025	Cola Michael F	Director	AGRANT◆	21,500	—	—	—	Open the original filing on SEC.gov
Jun 11, 2025	Barrett Elizabeth A.	Director	AGRANT◆	21,500	—	—	—	Open the original filing on SEC.gov
Apr 10, 2025	Greene Barry E	President and CEO	FTAX	4,862	$6.91	$33.6K	-4.6%	Open the original filing on SEC.gov
Apr 10, 2025	Greene Barry E	President and CEO	AGRANT	19,964	—	—	+23.5%	Open the original filing on SEC.gov
Apr 10, 2025	Benecchi Christopher	Chief Operating Officer	FTAX	661	$6.91	$4.6K	-1.4%	Open the original filing on SEC.gov
Apr 10, 2025	Benecchi Christopher	Chief Operating Officer	AGRANT	2,712	—	—	+5.9%	Open the original filing on SEC.gov
Apr 10, 2025	Benecchi Christopher	Chief Operating Officer	FTAX	793	$6.91	$5.5K	-1.7%	Open the original filing on SEC.gov
Apr 10, 2025	Benecchi Christopher	Chief Operating Officer	AGRANT	3,255	—	—	+7.4%	Open the original filing on SEC.gov

DTOISS◆—

Shiferman Gregory L. · See RemarksJul 31, 2025

28,000 sh

DTOISS◆—

Shiferman Gregory L. · See RemarksJul 31, 2025

10,000 sh

DTOISS—

Shiferman Gregory L. · See RemarksJul 31, 2025

23,735 sh · -100.0% own

UTENDR—

Shiferman Gregory L. · See RemarksJul 31, 2025

7,215 sh · -100.0% own

DTOISS◆—

Quirk Michael C. · See RemarksJul 31, 2025

4,000 sh

DTOISS◆—

Quirk Michael C. · See RemarksJul 31, 2025

36,000 sh

DTOISS—

Quirk Michael C. · See RemarksJul 31, 2025

7,962 sh · -100.0% own

DTOISS—

Quirk Michael C. · See RemarksJul 31, 2025

24,999 sh · -100.0% own

DTOISS◆—

Greene Barry E · President and CEOJul 31, 2025

174,000 sh

DTOISS—

Greene Barry E · President and CEOJul 31, 2025

53,229 sh · -100.0% own

UTENDR—

Greene Barry E · President and CEOJul 31, 2025

46,940 sh · -100.0% own

DTOISS◆—

Golumbeski George · DirectorJul 31, 2025

21,500 sh

DTOISS◆—

Golumbeski George · DirectorJul 31, 2025

13,593 sh

UTENDR—

Golumbeski George · DirectorJul 31, 2025

8,000 sh · -100.0% own

DTOISS◆—

Germano Geno J · DirectorJul 31, 2025

21,500 sh

DTOISS◆—

Federer Jessica · DirectorJul 31, 2025

21,500 sh

DTOISS◆—

Frates James M · DirectorJul 31, 2025

21,500 sh

DTOISS◆—

Frates James M · DirectorJul 31, 2025

19,154 sh

UTENDR—

Frates James M · DirectorJul 31, 2025

2,845 sh · -100.0% own

DTOISS◆—

Cola Michael F · DirectorJul 31, 2025

21,500 sh

DTOISS◆—

Benecchi Christopher · Chief Operating…Jul 31, 2025

40,000 sh

DTOISS◆—

Benecchi Christopher · Chief Operating…Jul 31, 2025

12,500 sh

DTOISS—

Benecchi Christopher · Chief Operating…Jul 31, 2025

36,375 sh · -100.0% own

DTOISS—

Benecchi Christopher · Chief Operating…Jul 31, 2025

28,053 sh · -100.0% own

DTOISS◆—

Barrett Elizabeth A. · DirectorJul 31, 2025

21,500 sh

UTENDR—

Barrett Elizabeth A. · DirectorJul 31, 2025

3,000 sh · -100.0% own

FTAX$728

Shiferman Gregory L. · See RemarksJun 24, 2025

79 sh @ $9.22 · -0.3% own

FTAX$1K

Quirk Michael C. · See RemarksJun 24, 2025

113 sh @ $9.22 · -0.4% own

AGRANT◆—

Golumbeski George · DirectorJun 11, 2025

21,500 sh

AGRANT◆—

Germano Geno J · DirectorJun 11, 2025

21,500 sh

AGRANT◆—

Federer Jessica · DirectorJun 11, 2025

21,500 sh

AGRANT◆—

Frates James M · DirectorJun 11, 2025

21,500 sh

AGRANT◆—

Cola Michael F · DirectorJun 11, 2025

21,500 sh

AGRANT◆—

Barrett Elizabeth A. · DirectorJun 11, 2025

21,500 sh

FTAX$33.6K

Greene Barry E · President and CEOApr 10, 2025

4,862 sh @ $6.91 · -4.6% own

AGRANT—

Greene Barry E · President and CEOApr 10, 2025

19,964 sh · +23.5% own

FTAX$4.6K

Benecchi Christopher · Chief Operating…Apr 10, 2025

661 sh @ $6.91 · -1.4% own

AGRANT—

Benecchi Christopher · Chief Operating…Apr 10, 2025

2,712 sh · +5.9% own

FTAX$5.5K

Benecchi Christopher · Chief Operating…Apr 10, 2025

793 sh @ $6.91 · -1.7% own

AGRANT—

Benecchi Christopher · Chief Operating…Apr 10, 2025

3,255 sh · +7.4% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 10 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →